ArticleBioImpacts : BI2026

Comprehensive pan-cancer analysis and experimental validation of mitotic arrest defective 2-like 1 (MAD2L1) in colorectal cancer.

Qingqing Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.